|
| Press Releases |
|
 |
|
| Saturday, August 24, 2024 |
|
|
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 |
| Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of its COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1. more info >> |
|
| Tuesday, March 26, 2024 |
|
|
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine |
| Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial, demonstrating a higher immune response against SARS-CoV-2 when compared to mRNA-1273.222, Moderna's licensed COVID-19 vaccine. more info >> |
|
| Monday, December 11, 2023 |
|
|
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event |
| more info >> |
|
| Wednesday, July 5, 2023 |
|
|
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345 |
| Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older. more info >> |
|
| Wednesday, May 3, 2023 |
|
|
Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines |
| Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an Enterprise Solutions Hub in the Philippines. The Moderna Enterprise Solutions Hub will provide business services across the Asia Pacific region, where Moderna currently has operations in six markets. Moderna also plans to establish commercial operations in the Philippines. more info >> |
|
| Tuesday, September 13, 2022 |
|
|
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Friday, September 9, 2022 |
|
|
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing process of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Tuesday, July 19, 2022 |
|
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years |
| Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 months to 5 years. more info >> |
|
| Thursday, February 17, 2022 |
|
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) |
| Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50 ug dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years. more info >> |
|
| Wednesday, February 16, 2022 |
|
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries |
| Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its commercial network across Asia with the addition of four new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong. This expansion comes as the Company continues to scale up the manufacturing and distribution of its COVID-19 vaccine and future mRNA vaccines and therapeutics. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Hong Kong Films @ Busan 2024 opens tomorrow
Oct 4, 2024 22:00 HKT/SGT
|
|
|
Antidote Announces $100M for Community Building and User Rewards 
Oct 4, 2024 19:00 HKT/SGT
|
|
|
Indonesia's Path to Society 5.0: Driving Digital Innovation at the Digital Transformation Summit
Oct 4, 2024 15:34 HKT/SGT
|
|
|
Pluk Phak Praw Rak Mae PCL (SET: OKJ) Eyes Expansion as the 'King of Organic Salad'
Oct 4, 2024 14:00 HKT/SGT
|
|
|
Fujitsu highlights technologies to realize its vision of AI as a trusted assistant at CEATEC 2024
Oct 4, 2024 11:03 JST
|
|
|
Four major tech fairs open in October
Oct 3, 2024 22:09 HKT/SGT
|
|
|
AVIA Announces "Vietnam in View" Conference, Highlighting Growth and Opportunities in Vietnam's Media and Entertainment Industry
Oct 3, 2024 19:30 HKT/SGT
|
|
|
ALUXE Unveils Enchanting New Winnie the Pooh Wedding Ring Collection
Oct 3, 2024 17:00 HKT/SGT
|
|
|
Toyota to Invest $500 Million in Joby Aviation
Oct 3, 2024 15:59 JST
|
|
|
CisgenX Awarded Smart Approved WaterMark Certification for Innovative Irrigation Solutions
Oct 3, 2024 14:47 HKT/SGT
|
|
|
Spa IZUMI Launches "YON-KA Phyto Sleep Ritual"
Oct 3, 2024 12:00 HKT/SGT
|
|
|
ADvance Pilipinas: "The Future of Advertising: Convergence and Divergence"
Oct 3, 2024 11:08 HKT/SGT
|
|
|
Fujitsu and Supermicro announce strategic collaboration to develop green AI computing technology and liquid-cooled datacenter solutions
Oct 3, 2024 9:38 JST
|
|
|
Insightful Discussions on eMobility Await: Join Influential Speakers at London EV Show 2024
Oct 2, 2024 18:36 HKT/SGT
|
|
|
Wadaoki Forest at the Mihara Machinery Works Certified as 'Nationally Certified Sustainably Managed Natural Site' by Ministry of the Environment
Oct 2, 2024 14:42 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
